Columbia Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-304
| Closed | -$320K | – | 205 |
|
|
2024
Q3 | $320K | Hold |
304
| – | – | 0.06% | 153 |
|
|
2024
Q2 | $320K | Buy |
304
+9
| +3% | +$9.47K | 0.06% | 147 |
|
|
2024
Q1 | $259K | Hold |
295
| – | – | 0.05% | 150 |
|
|
2023
Q4 | $259K | Sell |
295
-30
| -9% | -$26.3K | 0.05% | 150 |
|
|
2023
Q3 | $267K | Sell |
325
-40
| -11% | -$32.9K | 0.06% | 144 |
|
|
2023
Q2 | $262K | Sell |
365
-55
| -13% | -$39.5K | 0.06% | 150 |
|
|
2023
Q1 | $345K | Sell |
420
-250
| -37% | -$205K | 0.08% | 128 |
|
|
2022
Q4 | $483K | Hold |
670
| – | – | 0.12% | 113 |
|
|
2022
Q3 | $462K | Sell |
670
-20
| -3% | -$13.8K | 0.12% | 112 |
|
|
2022
Q2 | $408K | Buy |
+690
| New | +$408K | 0.1% | 117 |
|
|
2021
Q4 | $916K | Sell |
1,450
-100
| -6% | -$63.2K | 0.19% | 85 |
|
|
2021
Q3 | $938K | Buy |
1,550
+466
| +43% | +$282K | 0.2% | 84 |
|
|
2021
Q2 | $605K | Buy |
+1,084
| New | +$605K | 0.13% | 108 |
|
|
2019
Q2 | – | Sell |
-795
| Closed | -$326K | – | 203 |
|
|
2019
Q1 | $326K | Buy |
795
+310
| +64% | +$127K | 0.09% | 140 |
|
|
2018
Q4 | $181K | Hold |
485
| – | – | 0.06% | 163 |
|
|
2018
Q3 | $196K | Buy |
+485
| New | +$196K | 0.05% | 174 |
|